Nitric oxide for preventing pre-eclampsia and its complications

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Meher, Shireen ^a   Duley, L ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b NONE

Author keywords

Female; Nitric oxide donors therapeutic use ; Nitric oxide *therapeutic use ; Nitroglycerin therapeutic use ; Pre eclampsia *prevention control ; Randomized controlled trials as topic; Vasodilator agents *therapeutic use

Indexed keywords

ANTITHROMBOCYTIC AGENT; ARGININE; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; S NITROSOGLUTATHIONE; SILDENAFIL; TADALAFIL; VARDENAFIL;

ACCURACY; ANGINA PECTORIS; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; FLUSHING; FOLLOW UP; HEADACHE; HUMAN; HYPERTENSION; IMPOTENCE; INFORMATION PROCESSING; NONHUMAN; ORTHOSTATIC HYPOTENSION; PREECLAMPSIA; PROPHYLAXIS; PULMONARY HYPERTENSION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RASH; RELIABILITY; REVIEW; SIDE EFFECT; SKIN IRRITATION; TERATOGENICITY; TREATMENT OUTCOME;

EID: 44949108230     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006490     Document Type: Review

References (60)

1. Davis 2001 {published and unpublished data} Davis G, Brown M. Glyceryl trinitrate patches are unsuitable in hypertensive pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2001;41(4):474.
2. Facchinetti 2002 {published and unpublished data} Facchinetti F, Piccinini F, Pizzi C, Bukowski R, Volpe A, Saade G. Effect of arginine supplementation in patients with gestational hypertension. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S213.
3. Lees 1998 {published data only} Lees C, Valensise H, Black R, Harrington K, Byiers S, Romanini C, et al. The efficacy and fetal-maternal cardiovascular effects of transdermal glyceryl trinitrate in the prophylaxis of pre-eclampsia and its complications: a randomized double-blind placebo-controlled trial. Ultrasound in Obstetrics & Gynecology 1998;12(5):334-8.
4. Neri 1999 {published and unpublished data} Neri I, Valensise H, Facchinetti F, Menghini S, Romanini C, Volpe A. 24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. Hypertension in Pregnancy 1999;18(1):107-13.
5. Picciolo 2000 {published data only} Picciolo C, Roncaglia N, Neri I, Pasta F, Arreghini A, Facchinetti F. Nitric oxide in the prevention of pre-eclampsia. Prenatal and Neonatal Medicine 2000;5(4):212-5.
6. Zozulia 1997 {published data only} Zozulia O, Rogov VA, Piatakova NV, Tareeva IE. Nitric oxide: its role in the development of pregnancy complications and in their prevention in women with hypertension and chronic glomerulonephritis. Terapevticheskii Arkhiv 1997;69(6):17-20.
7. Amit 1998 Amit A, Thaler I, Paz Y, Itskovitz-Eldor J. The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy. Ultrasound in Obstetrics & Gynecology 1998;11(2):94-8.
8. Decano 2000 Decano MB, Cabrera LT. The effects of transdermal nitroglycerin (nitrol patch) on the uterine and umbilical artery blood flow in preeclampsia: a randomized double blind placebo controlled study [abstract]. XVI FIGO World Congress of Obstetrics & Gynecology (Book 1); 2000 Sept 3-8; Washington DC, USA. 2000:26.
9. Hladunewich 2006 Hladunewich MA, Derby GC, Lafayette RA, Blouch KL, Druzin ML, Myers BD. Effect of L-arginine therapy on the glomerular injury of preeclampsia. Obstetrics & Gynecology 2006;107(4):886-95.
10. Ledingham 1999 Ledingham MA, Denison FC, Kelly RW, Young A, Normal JE. Nitric oxide donors stimulate prostaglandin F2alpha and inhibit thromboxane B2 production in the human cervix during first trimester of pregnancy. Molecular Human Reproduction 1999;5(10):973-82.
11. Madhubala 2006 Madhubala M. Use of L-arginine in oligohydramnios. 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India. 2006:42.
12. Makino 1997 Makino Y, Izumi H, Makino I, Shirakawa K. The effect of nitric oxide on uterine and umbilical artery flow velocity waveform in preeclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology 1997;73(2):139-43.
13. Neri 2000b Neri I, Ternelli G, Facchinetti F, Volpe A. Effectiveness of oral nifedipine and transdermal glyceryltrinitrate on 24-hour blood pressure values in pregnancy-induced hypertension. Hypertension in Pregnancy 2000;19(Suppl 1):O65.
14. Neri 2004a Neri I, Blasi I, Facchinetti F. Effects of acute L-arginine infusion on non-stress test in hypertensive pregnant women. Journal of Maternal-Fetal & Neonatal Medicine 2004;16:23-6.
15. Neri 2004b Neri I, Jasonni VM, Gori G, Blasi I, Facchinetti F. Intravenous l-arginine is a new anti-hypertensive agent for pregnant women. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S42.
16. Reyna-Villasmil 2001 Reyna-Villasmil E, Prieto-Franchi M, Guerra-Velazquez M, Torres-Montilla M. Effect of transdermal nitroglycerin on umbilical artery blood flow in preeclampsia. Journal of Perinatal Medicine 2001;29 Suppl 1(Pt 2):486.
17. Ruggenenti 2006 Ruggenenti P. L-Arginine in pre-eclampsia. www.clinicaltrials.gov (accessed 21 March 2006).
18. Rytewski 2005 Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in pre-eclampsia. European Journal of Clinical Investigation 2005;35:32-7.
19. Rytlewski 2006 Rytlewski K, Olszanecki R, Lauterbach R, Grzyb A, Basta A. Effects of oral l-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. Basic & Clinical Pharmacology & Toxicology 2006;99:146-52.
20. Scarpellini 2001 Scarpellini F, Sbracia M, Lecchini S, Bolis P. Nitric oxide donor treatment reduces apoptosis in placental vessels of pregnancy induced hypertension. American Journal of Obstetrics and Gynecology 2001;185(6 Suppl):S177.
21. Staff 2004 Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstetricia et Gynecologica Scandinavica 2004;83(1):103-7.
22. Thaler 1999 Thaler I, Amit A, Kamil D, Itskovitz-Eldor J. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension. American Journal of Hypertension 1999;12(4 Pt 1):341-7.
23. Valensise 2005 Valensise H, Vasapollo B, Novelli GP, Altomare F, Arduini D. Nitric oxide donors and fluid therapy increase fetal growth in gestational hypertension. Ultrasound in Obstetrics & Gynecology 2005;26:440.
24. Benedetto 2000 Benedetto C, Marozio L, Neri I, Giarola M, Volpe A, Facchinetti F. Increased L-citrulline/L-arginine plasma ratio in severe preeclampsia. Obstetrics & Gynecology 2000;96(3):395-9.
25. Cockell 1997 Cockell AP, Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997;30(2):247-51.
26. Conrad 1999 Conrad KP, Kerchner LJ, Mosher MD. Plasma and 24-h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet. American Journal of Physiology 1999;2777(1):F48-F57.
27. Davidge 1996 Davidge ST, Stranko CP, Roberts JM. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. American Journal of Obstetrics and Gynecology 1996;174(3):1008-13.
28. De Caterina 1995 De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces expression of adhesion molecules and proinflammatory cytokines. Journal of Clinical Investigation 1995;96(1):60-8.
29. Delacretaz 1995 Delacretaz E, DeQuay N, Waeber B, Vial Y, Schulz PE, Burnier M, et al. Differential nitric oxide synthase activity in human platelets during normal pregnancy and pre-eclampsia. Clinical Sciences 1995;88:607-10.
30. DH 2002 Department of Health, Scottish Executive Health Department and Department of Health, Social Services, Public Safety. Northern Ireland. Why mothers die. The sixth report on confidential enquiries into maternal deaths in the United Kingdom 2000-2002. London: RCOG Press, 2002.
31. Di Iorio 1998 Di Ioro R, Marinoni E, Emiliani S, Villaccio B, Ermelando VC. Nitric oxide in preeclampsia: lack of evidence for decreased production. European Journal of Obstetrics & Gynecology and Reproductive Biology 1998;76(1):65-70.
32. Fickling 1993 Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GStJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242-3.
33. Generic Protocol 05 Meher S, Duley L, on behalf of the Prevention of Pre-eclampsia Cochrane Review authors. Interventions for prevention of pre-eclampsia and its consequences: generic protocol. Cochrane Database of Systematic Reviews 2005, Issue 2.
34. Grunewald 1995 Grunewald C, Kublickas M, Carlstrom K, Lunell N, Nisell H. Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstetrics & Gynecology 1995;86:600-4.
35. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005. In: The Cochrane Library, Issue 2, 2005. Chichester, UK: John Wiley & Sons, Ltd.
36. Hubel 1997 Hubel CA, Kagan VE, Kisin ER, McLaughlin MK, Roberts JM. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress. Free Radical Biology and Medicine 1997;23:597-609.
37. Ignarro 1987 Ignarro LJ, Buga GM, Wood KS, Byrne RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America 1987;84:9265-69.
38. Kubes 1991 Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences of the United States of America 1991;88:4651-5.
39. Lees 1996 Lees C, Langford E, Brown AS, de Belder A, Pickles A, Martin JF. The effects of S-nitrosoglutathione on platelet activation, hypertension, and uterine and fetal Doppler in severe preeclampsia. Obstetrics & Gynecology 1996;88:14-9.
40. Lowe 2000 Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000;4(4):441-58.
41. Lyall 1995 Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. American Journal of Obstetrics and Gynecology 1995;173(1):714-8.
42. Molnar 1994 Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. American Journal of Obstetrics and Gynecology 1994;170(1):1458-66.
43. Moncada 1991 Moncada S, Palmer RMJ, Higgs EA. Nitric oxide. Pharmacological Reviews 1991;43(2):109-42.
44. Morris 1995 Morris NH, Sooranna SR, Learmont JG, Poston L, Ramsey B, Peason JD, et al. Nitric oxide synthase activities in placental tissue from normotensive, preeclamptic, and growth retarded fetuses. British Journal of Obstetrics and Gynaecology 1995;102:711-4.
45. Myatt 1992 Myatt L, Brewer AS, Langdon G, Brockman DE. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. American Journal of Obstetrics and Gynecology 1992;166:224-30.
46. Neri 2000a Neri I, Piccinini F, Marietta M, Facchinetti F, Volpe A. Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertension in Pregnancy 2000;19(3):323-30.
47. NHBPEP2000 Gifford RW Jr, August PA, Cunningham G, Green LA, Lindhemier MD, McNellis D, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 2000;183(1):S1-S22.
48. Noris 2004 Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004;43(3):614-22.
49. Norris 1999 Norris L, Higgins JR, Darling MR, Walshe JJ, Bonnar J. Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulation in preeclampsia. Obstetrics & Gynecology 1999;93(6):958-63.
50. Palmer 1987 Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
51. Pinto 1991 Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. American Journal of Obstetrics and Gynecology 1991;164:507-13.
52. Poston 1998 Poston L. Nitrovasodilators - will they be useful in lowering uterine artery resistance in pre-eclampsia and intrauterine growth restriction?. Ultrasound in Obstetrics & Gynecology 1998;11:92-3.
53. Radomski 1987 Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2(8567):1057-8.
54. Ranta 1999 Ranta V, Viinikka L, Halmesmaki E, Ylikorkala O. Nitric oxide production with preeclampsia. Obstetrics & Gynecology 1999;93(3):442-5.
55. RevMan 2003 The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Oxford, England: The Cochrane Collaboration, 2003.
56. Seligman 1994 Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. American Journal of Obstetrics and Gynecology 1994;171:944-8.
57. Shaamash 2001 Shaamash AH, Elsonosy ED, Zakhari MM, Radwan SH, El-Dien HM. Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, pre-eclampsia, and eclampsia. International Journal of Gynecology & Obstetrics 2001;72(2):127-33.
58. Silver 1996 Silver RK, Kupferminc MJ, Russell TL, Adler L, Mullen TA, Caplan MS. Evaluation of nitric oxide as a mediator of severe preeclampsia. American Journal of Obstetrics and Gynecology 1996;175(4):1013-7.
59. Sladek 1997 Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. American Journal of Physiology 1997;272:R441-63.
60. WHO 1988 World Health Organization International Collaborative Study of Hypertensive Disorders in Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 1988;158:80-3.